WallStreetZenWallStreetZen

NYSE: ABBV
Abbvie Inc Stock

$175.14-0.61 (-0.35%)
Updated Feb 21, 2024
ABBV Price
$175.14
Fair Value Price
N/A
Market Cap
$309.38B
52 Week Low
$130.96
52 Week High
$178.92
P/E
64.15x
P/B
29.86x
P/S
5.04x
PEG
0.9x
Dividend Yield
3.42%
Revenue
$54.32B
Earnings
$4.86B
Gross Margin
62.4%
Operating Margin
14.59%
Profit Margin
9%
Debt to Equity
12
Operating Cash Flow
$23B
Beta
0.58
Next Earnings
N/A
Ex-Dividend
Apr 12, 2024
Next Dividend
May 15, 2024

ABBV Overview

AbbVie Inc. is a research focused biopharmaceutical company. The company produces pharmaceutical drugs for immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, virology, and other serious health conditions. The company was spun off from Abbott Laboratories in 2013 and is headquartered in North Chicago, IL.

Zen Score

Industry Average (43)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ABBV scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ABBV ($175.14) is trading above its intrinsic value of $83.22, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ABBV is poor value based on its earnings relative to its share price (64.15x), compared to the US market average (28.8x)
P/E vs Market Valuation
ABBV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ABBV due diligence checks available for Premium users.

Be the first to know about important ABBV news, forecast changes, insider trades & much more!

ABBV News

Valuation

ABBV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
64.15x
Industry
55.46x
Market
28.8x
ABBV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ABBV is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ABBV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
29.86x
Industry
5.87x
ABBV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ABBV price to earnings growth (PEG)

For valuing profitable companies with growth potential
ABBV is good value based... subscribe to Premium to read more.
PEG Value Valuation

ABBV's financial health

Profit margin

Revenue
$14.3B
Net Income
$822.0M
Profit Margin
5.7%
ABBV's Earnings (EBIT) of $7.92B... subscribe to Premium to read more.
Interest Coverage Financials
ABBV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$134.7B
Liabilities
$124.3B
Debt to equity
12
ABBV's short-term liabilities ($37.84B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ABBV's long-term liabilities ($86.47B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ABBV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ABBV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.8B
Investing
-$800.0M
Financing
-$4.4B
ABBV's operating cash flow ($22.84B)... subscribe to Premium to read more.
Debt Coverage Financials

ABBV vs General Drug Manufacturer Stocks

TickerMarket Cap1d %P/EP/B
ABBV$309.38B-0.35%64.15x29.86x
MRK$324.66B+0.59%70.78x7.87x
JNJ$382.22B+0.52%11.43x5.56x
NVS$209.64B-0.16%14.34x4.49x
AZN$201.80B+0.08%33.90x5.16x

Abbvie Stock FAQ

What is Abbvie's quote symbol?

(NYSE: ABBV) Abbvie trades on the NYSE under the ticker symbol ABBV. Abbvie stock quotes can also be displayed as NYSE: ABBV.

If you're new to stock investing, here's how to buy Abbvie stock.

What is the 52 week high and low for Abbvie (NYSE: ABBV)?

(NYSE: ABBV) Abbvie's 52-week high was $178.92, and its 52-week low was $130.96. It is currently -2.11% from its 52-week high and 33.74% from its 52-week low.

How much is Abbvie stock worth today?

(NYSE: ABBV) Abbvie currently has 1,766,473,359 outstanding shares. With Abbvie stock trading at $175.14 per share, the total value of Abbvie stock (market capitalization) is $309.38B.

Abbvie stock was originally listed at a price of $35.12 in Jan 2, 2013. If you had invested in Abbvie stock at $35.12, your return over the last 11 years would have been 398.69%, for an annualized return of 15.73% (not including any dividends or dividend reinvestments).

How much is Abbvie's stock price per share?

(NYSE: ABBV) Abbvie stock price per share is $175.14 today (as of Feb 21, 2024).

What is Abbvie's Market Cap?

(NYSE: ABBV) Abbvie's market cap is $309.38B, as of Feb 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Abbvie's market cap is calculated by multiplying ABBV's current stock price of $175.14 by ABBV's total outstanding shares of 1,766,473,359.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.